Food companies are betting big on MAHA snacks

Protein Pop-Tarts and avocado-oil chips promise better health outcomes. Do they deliver? ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

April 22, 2026 Check out STAT+

Sponsored By

Camille MacMillin/STAT Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush From protein Pop-Tarts to avocado-oil chips, a MAHA-fueled snack revolution promises healthier eating. Nutrition experts say it may mostly be illusion. By Sarah Todd Live: Robert F. Kennedy Jr. testifies before Senate HELP committee Live coverage of RFK Jr.'s testimony before the Senate Health, Education, Labor, and Pensions committee on the proposed HHS budget and MAHA priorities. By Chelsea Cirruzzo and Daniel Payne Increased calls to 988 hotline associated with a drop in suicides among young people, study finds A new study finds young people's suicide rates fell after 988 launched, especially where more calls were answered, but funding issues remain. By Theresa Gaffney Camille MacMillin/STAT; Sources: AP, CDC, Adobe Opinion: The CDC’s ‘disease detective’ program turns 75 Celebrating 75 years of the Epidemic Intelligence Service’s crucial work in public health in the U.S. and around the world. By Eric J. Chow, Ariella Perry Dale, and Matthew Donahue STAT+ | From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond. By Angus Chen STAT+ | Gene therapy trial for deafness adds evidence to drug’s efficacy Study finds 90% of participants reported significant improvement from an experimental gene therapy designed to treat a rare type of congenital hearing loss. By O. Rose Broderick Opinion: Behind every miracle drug is a story Thomas Goetz, host of "Drug Story," on how his podcast explores the intersection of medication and modern life. By Torie Bosch Opinion: NASA’s plans for living in space should prioritize immunology and infectious disease As NASA moves forward with plans for the moon and Mars, it must consider is the potential impacts of immunology and infectious disease. By Scott E. Solomon

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser